Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Deloitte
Teva
AstraZeneca
Harvard Business School
Moodys
Johnson and Johnson
Baxter
Merck

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074917

« Back to Dashboard

NDA 074917 describes FENTANYL CITRATE PRESERVATIVE FREE, which is a drug marketed by Hospira, Watson Labs Inc, and West-ward Pharms Int, and is included in three NDAs. It is available from two suppliers. Additional details are available on the FENTANYL CITRATE PRESERVATIVE FREE profile page.

The generic ingredient in FENTANYL CITRATE PRESERVATIVE FREE is fentanyl citrate. There are thirty-one drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the fentanyl citrate profile page.
Summary for 074917
Tradename:FENTANYL CITRATE PRESERVATIVE FREE
Applicant:Watson Labs Inc
Ingredient:fentanyl citrate
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 0.05MG BASE/ML
Approval Date:Feb 3, 1998TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Medtronic
US Army
Argus Health
Boehringer Ingelheim
Colorcon
Accenture
Moodys
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.